We are live on ! Find out more
AXDX

Accelerate Diagnostics
AXDX

Delisted

AXDX was delisted on the 14th of May, 2025.

Back to rankings

112 hedge funds and large institutions have $311M invested in Accelerate Diagnostics in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 28 increasing their positions, 36 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

9% less funds holding

Funds holding: 123 → 112 (-11)

22% less repeat investments, than reductions

Existing positions increased: 28 | Existing positions reduced: 36

31% less capital invested

Capital invested by funds: $448M → $311M (-$137M)

58% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 19

63% less call options, than puts

Call options by funds: $1.18M | Put options by funds: $3.18M

Holders
112
Holders Change
-11
Holders Change %
-8.94%
% of All Funds
2.26%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
8
Increased
28
Reduced
36
Closed
19
Calls
$1.18M
Puts
$3.18M
Net Calls
-$2M
Net Calls Change
+$787K

Top Buyers

1
CC
Chicago Capital
Illinois
+$16.8M
2
N
Nuveen
North Carolina
+$3.16M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$1.82M
4
Bank of America
Bank of America
North Carolina
+$1.6M
5
First Trust Advisors
First Trust Advisors
Illinois
+$1.25M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$4.77M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$4.11M
3
SM
Senvest Management
New York
-$4M
4
Axa
Axa
France
-$3.33M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$2.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$2.12M +$171K +1,231 +7%
BAMCO Inc
27
BAMCO Inc
New York
$1.76M – – –
OCMI
28
Oaktop Capital Management II
New Jersey
$1.65M – – –
Bank of America
29
Bank of America
North Carolina
$1.62M +$1.6M +11,505 +312%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$1.4M -$12.4K -89 -0.7%
First Trust Advisors
31
First Trust Advisors
Illinois
$958K +$1.25M +8,986 New
CCM
32
Cadian Capital Management
New York
$954K +$1.24M +8,947 New
Wells Fargo
33
Wells Fargo
California
$940K +$608K +4,380 +99%
Susquehanna International Group
34
Susquehanna International Group
Pennsylvania
$889K -$2.6M -18,716 -69%
Renaissance Technologies
35
Renaissance Technologies
New York
$819K +$1.07M +7,680 New
Swiss National Bank
36
Swiss National Bank
Switzerland
$731K – – –
Tudor Investment Corp
37
Tudor Investment Corp
Connecticut
$723K +$677K +4,879 +257%
California Public Employees Retirement System
38
California Public Employees Retirement System
California
$689K +$40.3K +290 +5%
Barclays
39
Barclays
United Kingdom
$659K -$67.1K -483 -7%
TWA
40
TCI Wealth Advisors
Arizona
$593K – – –
CSS
41
Cubist Systematic Strategies
Connecticut
$566K +$420K +3,028 +133%
TIM
42
Thompson Investment Management
Wisconsin
$564K – – –
PFM
43
Premier Fund Managers
United Kingdom
$542K -$995K -7,166 -59%
TMC
44
Trellus Management Company
Florida
$499K -$44K -317 -6%
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$499K +$11.2K +81 +2%
AllianceBernstein
46
AllianceBernstein
Tennessee
$479K -$115K -830 -16%
Group One Trading
47
Group One Trading
Illinois
$479K +$314K +2,263 +102%
Two Sigma Investments
48
Two Sigma Investments
New York
$463K +$258K +1,855 +75%
PPA
49
Parametric Portfolio Associates
Washington
$451K -$9.3K -67 -2%
OFG
50
Oxford Financial Group
Indiana
$447K – – –
1
2
3 4 5

AXDX Hedge Fund Activity: Q3 2020 in Review

112 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q3 2020, worth a combined $311M — down 31% from $448M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of AXDX and 8 opened new positions — a net loss of 11 holders — while 36 trimmed existing stakes and 28 added.

The largest buyer was Chicago Capital, adding an estimated $16.8M. The largest seller was Morgan Stanley, cutting an estimated $4.77M.

  • 112 institutional investors held Accelerate Diagnostics (AXDX) as of Q3 2020, down from 123 in Q2 2020.
  • Funds reported $311M of Accelerate Diagnostics stock for Q3 2020, down 31% quarter-over-quarter.
  • 8 funds opened new Accelerate Diagnostics positions in Q3 2020 and 19 closed out, a net change of -11 holders.
  • The largest Accelerate Diagnostics buyer in Q3 2020 was Chicago Capital, an estimated $16.8M added.
  • The largest Accelerate Diagnostics seller in Q3 2020 was Morgan Stanley, an estimated $4.77M sold.

Based on aggregated 13F filings for Q3 2020.